|
Teva snags an EU recommendation for its asthma, COPD inhaler
FierceDrugDelivery European regulatory authorities gave Teva ($TEVA) a positive opinion for its DuoResp Spiromax inhalation powder, designed to treat asthma and chronic obstructive pulmonary disease (COPD). With the recommendation from the Committee for Medicinal … |
View full post on asthma – Google News